Editas MedicineEDIT
EDIT
$3.77
3.58%
Market Cap: $311M
0
Funds holding %
of 6,710 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
43% more call options, than puts
Call options by funds: $2.61M | Put options by funds: $1.83M
18% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 40
3% more funds holding
Funds holding: 223 [Q1] → 230 (+7) [Q2]
7% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 70
16.66% less ownership
Funds ownership: 85.19% [Q1] → 68.53% (-16.66%) [Q2]
49% less capital invested
Capital invested by funds: $517M [Q1] → $263M (-$254M) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$7
86%
upside
Avg. target
$11
192%
upside
High target
$15
298%
upside
5 analyst ratings
3 positive
60%
2 neutral
40%
0 negative
0%
RBC Capital Luca Issi 33% 1-year accuracy 16 / 49 met price target | 112%upside $8 | Sector Perform Reiterated | 19 Sept 2024 |
Jones Trading Soumit Roy 44% 1-year accuracy 4 / 9 met price target | 245%upside $13 | Buy Initiated | 17 Sept 2024 |
Barclays Gena Wang 41% 1-year accuracy 9 / 22 met price target | 86%upside $7 | Equal-Weight Maintained | 8 Aug 2024 |
Truist Securities Joon Lee 67% 1-year accuracy 30 / 45 met price target | 218%upside $12 | Buy Maintained | 8 Aug 2024 |
B of A Securities Greg Harrison 29% 1-year accuracy 2 / 7 met price target | 298%upside $15 | Buy Upgraded | 8 Aug 2024 |
Financial journalist opinion
Based on 5 articles about EDIT published over the past 30 days